%0 Journal Article
%T 二肽基肽酶4抑制剂对老年2型糖尿病合并动脉粥样硬化调节作用的研究进展<br>Research Progress of Dipeptidyl Eptidase 4 Inhibitors in Elderly Patients with Type 2 Diabetes Mellitus Complicated with Atherosclerosis
%A 赵泽洋
%A 杨青岩
%J Advances in Clinical Medicine
%P 12393-12400
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.1381737
%X 二肽基肽酶4抑制剂近年来已在临床上广泛应用。越来越多的证据表明二肽基肽酶4抑制剂在2型糖尿病治疗中除了降血糖作用外，还具有对心血管系统的保护调节作用，临床中特别是对老年2型糖尿病合并动脉粥样硬化患者的治疗有一定的作用，但目前对二肽基肽酶4抑制剂在心血管方面的调节作用研究方面争议较大，本文就二肽基肽酶4抑制剂对动脉粥样硬化调节作用的研究进展进行总结和论述。<br />
Dipeptidyl peptidase 4 inhibitors have been widely used in clinical practice in recent years. More and more evidence has shown that dipeptidyl peptidase 4 inhibitors have a protective regulatory effect on the cardiovascular system in addition to hypoglycemic effect in the treatment of type 2 di-abetes mellitus, especially in the treatment of elderly patients with type 2 diabetes mellitus com-plicated with atherosclerosis. However, the research on the regulatory effect of dipeptidyl peptidase 4 inhibitors on cardiovascular aspects is controversial. In this paper, the research progress of di-peptidyl peptidase 4 inhibitors against atherosclerosis is summarized and discussed.
%K 二肽基肽酶4抑制剂，老年2型糖尿病，动脉粥样硬化，老年2型糖尿病合并动脉粥样硬化<br>Dipeptidyl Peptidase 4 Inhibitors
%K Elderly Type 2 Diabetes Mellitus
%K Atherosclerosis
%K Elderly Type 2 Diabetes Mellitus Complicated with Atherosclerosis
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=70341